tanshinone has been researched along with Di Guglielmo Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cen, J; Guan, T; Li, YM; Tang, XZ; Yan, F; Zhen, X | 1 |
| An, KS; Choi, SM; Sung, HJ; Yoon, Y | 1 |
2 other study(ies) available for tanshinone and Di Guglielmo Disease
| Article | Year |
|---|---|
Cytotoxic effect and apoptotic mechanism of tanshinone A, a novel tanshinone derivative, on human erythroleukemic K562 cells.
Topics: Abietanes; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Cycle; Gene Expression Regulation, Neoplastic; Humans; K562 Cells; Leukemia, Erythroblastic, Acute; Membrane Potential, Mitochondrial; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Signal Transduction | 2011 |
Tanshinone IIA, an ingredient of Salvia miltiorrhiza BUNGE, induces apoptosis in human leukemia cell lines through the activation of caspase-3.
Topics: Abietanes; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Caspases; Cell Cycle; DNA Fragmentation; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Enzyme Activation; HL-60 Cells; Humans; Lamiaceae; Leukemia; Leukemia, Erythroblastic, Acute; Phenanthrenes; Tumor Cells, Cultured | 1999 |